1 Item 1A. Risk Factors 28 Item 1B. Unresolved Staff Comments 74 Item 1C. Cybersecurity 74 Item 2. Properties 75 Item 3. Legal Proceedings 75 Item 4. Mine Safety Disclosures 75 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 76 Item 6. [Reserved] 76 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 77 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 92 Item 8....
Q2 FY2026 — expected 2026-08-06
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-10 | 2025-12-31 | 0001193125-26-099339 | EDGAR | 104K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-036823 | EDGAR | — |
| 2024-03-13 | 2023-12-31 | 0000950170-24-030478 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0000950170-23-006995 | EDGAR | — |
| 2022-03-23 | 2021-12-31 | 0000950170-22-004401 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012490 | EDGAR | — |
| 2020-03-12 | 2019-12-31 | 0001564590-20-010441 | EDGAR | — |
| 2019-03-12 | 2018-12-31 | 0001564590-19-007250 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-278812 | EDGAR | 76K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-103530 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0000950170-25-066371 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-122785 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093305 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056273 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0000950170-23-063667 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042360 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0000950170-23-021177 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024431 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017367 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0000950170-22-010065 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-27 | 0001193125-26-129431 | EDGAR | 26K words |
| 2026-03-10 | 0001193125-26-099328 | EDGAR | — |
| 2026-02-17 | 0001193125-26-054711 | EDGAR | — |
| 2025-12-19 | 0001193125-25-326821 | EDGAR | — |
| 2025-12-01 | 0001193125-25-303115 | EDGAR | — |
| 2025-11-13 | 0001193125-25-278805 | EDGAR | — |
| 2025-10-21 | 0001193125-25-244262 | EDGAR | — |
| 2025-08-06 | 0000950170-25-103526 | EDGAR | — |
| 2025-06-25 | 0001193125-25-146179 | EDGAR | — |
| 2025-06-17 | 0001193125-25-142039 | EDGAR | — |
113 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001661998 |
| Ticker | QTTB |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.q32bio.com |
| Listed | 2024-03-26 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report